Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 01, 2024

SELL
$8.02 - $8.67 $1.14 Million - $1.23 Million
-141,610 Reduced 51.85%
131,492 $1.12 Million
Q4 2023

Jan 31, 2024

SELL
$7.78 - $8.62 $387,910 - $429,793
-49,860 Reduced 15.44%
273,102 $2.25 Million
Q3 2023

Oct 31, 2023

SELL
$7.85 - $8.94 $676,905 - $770,896
-86,230 Reduced 21.07%
322,962 $2.69 Million
Q2 2023

Aug 01, 2023

SELL
$8.04 - $9.0 $1.79 Million - $2.01 Million
-222,915 Reduced 35.27%
409,192 $3.43 Million
Q1 2023

May 09, 2023

SELL
$7.57 - $8.37 $63,845 - $70,592
-8,434 Reduced 1.32%
632,107 $5.15 Million
Q4 2022

Feb 02, 2023

SELL
$5.96 - $8.06 $283,326 - $383,156
-47,538 Reduced 6.91%
640,541 $5.12 Million
Q3 2022

Nov 03, 2022

BUY
$5.63 - $7.5 $3.87 Million - $5.16 Million
688,079 New
688,079 $4.19 Million

Others Institutions Holding HLN

About Haleon plc


  • Ticker HLN
  • Exchange
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 4,617,290,240
  • Market Cap $43.4B
  • Description
  • Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, mineral...
More about HLN
Track This Portfolio

Track Kornitzer Capital Management Inc Portfolio

Follow Kornitzer Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kornitzer Capital Management Inc , based on Form 13F filings with the SEC.

News

Stay updated on Kornitzer Capital Management Inc with notifications on news.